Correlation Between Verrica Pharmaceuticals and 126650BQ2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Verrica Pharmaceuticals and US126650BQ21, you can compare the effects of market volatilities on Verrica Pharmaceuticals and 126650BQ2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of 126650BQ2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and 126650BQ2.
Diversification Opportunities for Verrica Pharmaceuticals and 126650BQ2
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Verrica and 126650BQ2 is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and US126650BQ21 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US126650BQ21 and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with 126650BQ2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US126650BQ21 has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and 126650BQ2 go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and 126650BQ2
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 2.74 times more return on investment than 126650BQ2. However, Verrica Pharmaceuticals is 2.74 times more volatile than US126650BQ21. It trades about 0.07 of its potential returns per unit of risk. US126650BQ21 is currently generating about 0.0 per unit of risk. If you would invest 227.00 in Verrica Pharmaceuticals on February 28, 2024 and sell it today you would earn a total of 629.00 from holding Verrica Pharmaceuticals or generate 277.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 19.96% |
Values | Daily Returns |
Verrica Pharmaceuticals vs. US126650BQ21
Performance |
Timeline |
Verrica Pharmaceuticals |
US126650BQ21 |
Verrica Pharmaceuticals and 126650BQ2 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verrica Pharmaceuticals and 126650BQ2
The main advantage of trading using opposite Verrica Pharmaceuticals and 126650BQ2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, 126650BQ2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 126650BQ2 will offset losses from the drop in 126650BQ2's long position.Verrica Pharmaceuticals vs. MicroAlgo | Verrica Pharmaceuticals vs. Morningstar Unconstrained Allocation | Verrica Pharmaceuticals vs. T Rowe Price | Verrica Pharmaceuticals vs. Nt International Small Mid |
126650BQ2 vs. US BANK NATIONAL | 126650BQ2 vs. AEP TEX INC | 126650BQ2 vs. Dover | 126650BQ2 vs. Nokia Corp ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |